Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Epidemiological and Clinical-pathological Factors of Philadelphia-negative Myeloproliferative Neoplasms in Ecuador

NCT05825326 is registered in ClinicalTrials.gov with Sociedad de Lucha Contra el Cáncer del Ecuador as lead sponsor.

NCT NCT05825326
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05825326 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Epidemiological and Clinical-pathological Factors of Philadelphia-negative Myeloproliferative Neoplasms in Ecuador
Lead sponsor
Sociedad de Lucha Contra el Cáncer del Ecuador
Phase
Observational
Overall status
Completed
Start date
January 1, 2012
Completion date
December 31, 2019
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myeloproliferative disease, not classified, myeloproliferative disorders, myeloproliferative neoplasm, myeloproliferative neoplasm, unclassifiable, myeloproliferative syndrome